Insulin Lispro is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Lispro.
Product ID | 0002-7737_1dad7c5d-c1d7-4d83-9856-0aff8f50e183 |
NDC | 0002-7737 |
Product Type | Human Prescription Drug |
Proprietary Name | Insulin Lispro |
Generic Name | Insulin Lispro |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2020-02-12 |
Marketing Category | BLA / NDA AUTHORIZED GENERIC |
Application Number | BLA020563 |
Labeler Name | Eli Lilly and Company |
Substance Name | INSULIN LISPRO |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-02-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA authorized generic |
Application Number | NDA020563 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-02-12 |
Ingredient | Strength |
---|---|
INSULIN LISPRO | 100 [iU]/mL |
SPL SET ID: | 97d5e596-aae1-42c9-ae89-c3780959c467 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
66733-773 | Insulin lispro | Insulin lispro |
70518-2398 | Insulin lispro | Insulin lispro |
0002-7737 | Insulin Lispro | Insulin Lispro |
70518-2802 | Insulin Lispro | Insulin Lispro |
50090-5391 | Insulin Lispro | Insulin Lispro |
0002-7510 | Humalog | Insulin lispro |
0002-7511 | Humalog | Insulin lispro |
0002-7512 | Humalog | Insulin lispro |
0002-7516 | Humalog | Insulin lispro |
0002-7712 | Humalog | Insulin lispro |
0002-7714 | Humalog | Insulin lispro |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INSULIN LISPRO 87691956 5475637 Live/Registered |
Sanofi 2017-11-20 |